Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment — Stella

Home/Hepatocellular Carcinoma/

View on ClinicalTrials.gov

Recruiting

Back to Hepatocellular Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Tennessee Medical Center, Knoxville, Tennessee

Key details

Sponsor

University of Tennessee

Collaborators

Biocompatibles UK Ltd

Enrollment target

~20 participants

Started

June 2018

Primary completion

June 2019

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2018

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.